| scholarly article | Q13442814 |
| P50 | author | Candice M Brown | Q74334070 |
| Vidula Vachharajani | Q42398906 | ||
| P2093 | author name string | Xianfeng Wang | |
| Charles E McCall | |||
| Barbara K Yoza | |||
| Nancy L Buechler | |||
| Tiefu Liu | |||
| Jonathan David Wells | |||
| P2860 | cites work | After Xigris, researchers look to new targets to combat sepsis | Q44161242 |
| Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules | Q44342200 | ||
| Benchmarking the incidence and mortality of severe sepsis in the United States | Q45240119 | ||
| Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain | Q48930604 | ||
| Resveratrol attenuates high-fat diet-induced disruption of the blood-brain barrier and protects brain neurons from apoptotic insults. | Q52649064 | ||
| The effect of resveratrol on neurodegeneration and blood brain barrier stability surrounding intracortical microelectrodes | Q56926302 | ||
| The search for effective therapy for sepsis: back to the drawing board? | Q57151020 | ||
| Leukocyte-endothelial cell interactions in diabetic retina after transient retinal ischemia | Q74217849 | ||
| Depletion of dendritic cells, but not macrophages, in patients with sepsis | Q77671545 | ||
| Injury of the blood brain barrier and up-regulation of icam-1 in polymicrobial sepsis | Q80420788 | ||
| Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis | Q84255932 | ||
| Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase | Q24293656 | ||
| Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation | Q24682128 | ||
| Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism | Q27679007 | ||
| SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity | Q28484104 | ||
| Macrophages, inflammation, and insulin resistance | Q29614351 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis | Q33749945 | ||
| Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity | Q34247997 | ||
| NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. | Q34281758 | ||
| Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders | Q34351149 | ||
| Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance | Q34578490 | ||
| Endotoxin tolerance-current concepts in historical perspective | Q34655790 | ||
| NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance | Q34684804 | ||
| The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome | Q35051545 | ||
| Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment | Q35113561 | ||
| Endotoxin tolerance: is there a clinical relevance? | Q35153199 | ||
| SirT1 regulates adipose tissue inflammation | Q35561122 | ||
| Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions | Q35764552 | ||
| Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain | Q35784810 | ||
| Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
| Fueling the flame: bioenergy couples metabolism and inflammation | Q36188905 | ||
| TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT. | Q36260870 | ||
| Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle | Q36739504 | ||
| Biomarkers of endothelial cell activation in early sepsis | Q36894829 | ||
| The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance | Q37459848 | ||
| Gene-Specific Epigenetic Regulation in Serious Infections with Systemic Inflammation | Q37781968 | ||
| Sepsis-induced intestinal microvascular and inflammatory responses in obese mice. | Q38288833 | ||
| The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. | Q40752165 | ||
| The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins | Q41346155 | ||
| Immunotherapy for sepsis--a new approach against an ancient foe. | Q42802907 | ||
| Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? | Q43461783 | ||
| Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? | Q43688196 | ||
| P433 | issue | 5 | |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 785-796 | |
| P577 | publication date | 2014-07-07 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome | |
| P478 | volume | 96 |
| Q37338105 | Adiponectin treatment attenuates inflammatory response during early sepsis in obese mice. |
| Q59136624 | Cellular metabolism constrains innate immune responses in early human ontogeny |
| Q92071956 | Dual Deletion of the Sirtuins SIRT2 and SIRT3 Impacts on Metabolism and Inflammatory Responses of Macrophages and Protects From Endotoxemia |
| Q38669814 | Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward? |
| Q59796141 | Emerging Evidence concerning the Role of Sirtuins in Sepsis |
| Q93172729 | Epigenetic and metabolic programming of innate immunity in sepsis |
| Q41991798 | Epigenetic regulation in bacterial infections: targeting histone deacetylases |
| Q55000739 | High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells. |
| Q28081001 | Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases |
| Q40046316 | IκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response. |
| Q49917338 | Mechanisms of Organ Dysfunction in Sepsis. |
| Q39089885 | Metabolic reprogramming and tolerance during sepsis-induced AKI. |
| Q47114602 | MiR-6835 promoted LPS-induced inflammation of HUVECs associated with the interaction between TLR-4 and AdipoR1 in lipid rafts. |
| Q52338709 | Mitochondrial Sirtuin 4 Resolves Immune Tolerance in Monocytes by Rebalancing Glycolysis and Glucose Oxidation Homeostasis. |
| Q38769949 | New insights into the gut as the driver of critical illness and organ failure |
| Q58792292 | Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival |
| Q38724278 | Recent developments in severe sepsis research: from bench to bedside and back |
| Q92238807 | Regulation of Adaptive Immune Cells by Sirtuins |
| Q64236064 | Regulation of Monocyte-Macrophage Responses in Cirrhosis-Role of Innate Immune Programming and Checkpoint Receptors |
| Q64076143 | Resveratrol Reduced Liver Damage After Liver Resection in a Rat Model by Upregulating Sirtuin 1 (SIRT1) and Inhibiting the Acetylation of High Mobility Group Box 1 (HMGB1) |
| Q35655821 | Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice |
| Q41612831 | SIRT1 inhibition promotes atherosclerosis through impaired autophagy |
| Q35582696 | SIRT1 is a regulator in high glucose-induced inflammatory response in RAW264.7 cells |
| Q39972142 | SIRT1 mediates a primed response to immune challenge after traumatic lung injury. |
| Q28817614 | SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model |
| Q47593859 | SRT1720, a sirtuin 1 activator, attenuates organ injury and inflammation in sepsis |
| Q38453261 | Sepsis: a roadmap for future research |
| Q34801529 | Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. |
| Q64057066 | Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress |
| Q33631234 | Sirtuin 2 Regulates Microvascular Inflammation during Sepsis. |
| Q36097432 | Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice |
| Q90702451 | Sirtuin1 Targeting Reverses Innate and Adaptive Immune Tolerance in Septic Mice |
| Q26767141 | Sirtuins Link Inflammation and Metabolism |
| Q58742374 | Sirtuins and Immuno-Metabolism of Sepsis |
| Q91891483 | Systemic inhibition of tissue-nonspecific alkaline phosphatase alters the brain-immune axis in experimental sepsis |
| Q41478878 | The Oxidative State of Cysteine Thiol 144 Regulates the SIRT6 Glucose Homeostat. |
| Q36065527 | The SIRT1 promoter polymorphic site rs12778366 increases IL-6 related human mortality in the prospective study "Treviso Longeva (TRELONG)". |
| Q48169996 | The grapes and wrath: using resveratrol to treat the pathophysiology of hemorrhagic shock |
| Q30234689 | The immunopathology of sepsis and potential therapeutic targets |
| Q92366410 | miR‑195 promotes LPS‑mediated intestinal epithelial cell apoptosis via targeting SIRT1/eIF2a |
Search more.